1. Home
  2. SNY

as 08-08-2025 10:42am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Founded: 1994 Country:
France
France
Employees: N/A City: N/A
Market Cap: 116.5B IPO Year: N/A
Target Price: $65.00 AVG Volume (30 days): 2.3M
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
3.37%
Dividend Payout Frequency: Annual
EPS: 8.65 EPS Growth: 118.56
52 Week Low/High: $44.73 - $60.12 Next Earning Date: 07-31-2025
Revenue: $53,714,621,258 Revenue Growth: 15.65%
Revenue Growth (this year): 2.85% Revenue Growth (next year): 6.65%

SNY Daily Stock ML Predictions

Share on Social Networks: